Search research articles
Contact Us
Filters
Showing results (181-190 of 206) with videos related to
Page
of 21
Sort By:
Cancers
|
September 23, 2022
Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial
Takao Takahashi, Kazuyuki Ishida, Yasunori Emi, et al.
Cancer Science
|
June 15, 2021
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA
Kuniko Sunami, Hideaki Bando, Yasushi Yatabe, et al.
Frontiers in Oncology
|
September 22, 2022
Quantitative high-throughput analysis of tumor infiltrating lymphocytes in breast cancer
Kumiko Hayashi, Daichi Nogawa, Maki Kobayashi, et al.
Anaerobe
|
October 8, 2023
Clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer
Yuriko Matsumiya, Mitsukuni Suenaga, Toshiaki Ishikawa, et al.
Clinical Colorectal Cancer
|
February 27, 2017
Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer
Takayuki Yoshino, Hiroyuki Uetake, Katsuya Tsuchihara, et al.
Cancer
|
October 8, 2015
International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening
Takuya Okada, Koji Tanaka, Hiroshi Kawachi, et al.
The American Journal of Surgical Pathology
|
September 2, 2020
Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial)
Hideki Ueno, Megumi Ishiguro, Eiji Nakatani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2021
EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Raju Kandimalla, Jianfeng Xu, Alexander Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2019
Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial
Hideki Ueno, Megumi Ishiguro, Eiji Nakatani, et al.
British Journal of Cancer
|
January 8, 2021
Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial)
Hideki Ueno, Megumi Ishiguro, Eiji Nakatani, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 206) with videos related to
Sort By:
Page
of 21
Cancers
|
September 23, 2022
Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial
Takao Takahashi, Kazuyuki Ishida, Yasunori Emi, et al.
Cancer Science
|
June 15, 2021
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA
Kuniko Sunami, Hideaki Bando, Yasushi Yatabe, et al.
Frontiers in Oncology
|
September 22, 2022
Quantitative high-throughput analysis of tumor infiltrating lymphocytes in breast cancer
Kumiko Hayashi, Daichi Nogawa, Maki Kobayashi, et al.
Anaerobe
|
October 8, 2023
Clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer
Yuriko Matsumiya, Mitsukuni Suenaga, Toshiaki Ishikawa, et al.
Clinical Colorectal Cancer
|
February 27, 2017
Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer
Takayuki Yoshino, Hiroyuki Uetake, Katsuya Tsuchihara, et al.
Cancer
|
October 8, 2015
International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening
Takuya Okada, Koji Tanaka, Hiroshi Kawachi, et al.
The American Journal of Surgical Pathology
|
September 2, 2020
Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial)
Hideki Ueno, Megumi Ishiguro, Eiji Nakatani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2021
EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers
Raju Kandimalla, Jianfeng Xu, Alexander Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2019
Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial
Hideki Ueno, Megumi Ishiguro, Eiji Nakatani, et al.
British Journal of Cancer
|
January 8, 2021
Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial)
Hideki Ueno, Megumi Ishiguro, Eiji Nakatani, et al.
Page
of 21